Literature DB >> 19699663

Postoperative bypass bleeding: a bypass-associated dilutional (BAD) coagulopathy?

Brian S Bull1, Karen L Hay, Paul C Herrmann.   

Abstract

A number of associations with post-bypass bleeding have been described in the accompanying paper. Herein we hypothesize that dilution is an underlying cause through a malign series of bypass-associated events. Heparinized blood behaves anomalously when diluted. Clotting times first shorten somewhat, then--as the dilution of whole blood approaches 50%--rapidly lengthen to unclottability. During cardiopulmonary bypass, low blood volume patients are at a significant risk of clotting factor dilution which will always be more severe than the level of whole blood dilution. If severe enough, this dilution may lower plasma clotting factors to a critical level and may result in excess protamine administration, secondary to overestimation of heparin. The presence of un-neutralized protamine combined with critically lowered clotting factors leads to marked coagulopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19699663     DOI: 10.1016/j.bcmd.2009.07.002

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  4 in total

1.  Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery.

Authors:  Vrigina Arnékian; Julien Camous; Soly Fattal; Saida Rézaiguia-Delclaux; Rémi Nottin; François Stéphan
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-05-23

2.  Prothrombin complex concentrate mitigates diffuse bleeding after cardiopulmonary bypass in a porcine model.

Authors:  F Kaspereit; S Hoffmann; I Pragst; G Dickneite
Journal:  Br J Anaesth       Date:  2010-08-17       Impact factor: 9.166

3.  Which factors have a great impact on coagulopathy and hemostatic impairment after cardiopulmonary bypass in cardiovascular surgery? An analysis based on rotational thromboelastometry.

Authors:  Kenshi Yoshimura; Hirotsugu Hamamoto; Takafumi Abe; Norio Itai; Shuichiro Uehara; Takuya Tsusue; Satomi Tahara; Hideo Iwasaka; Hiroki Sato; Shinji Miyamoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2021-08-13

4.  Nonclinical evaluation of novel cationically modified polysaccharide antidotes for unfractionated heparin.

Authors:  Bartlomiej Kalaska; Kamil Kaminski; Emilia Sokolowska; Dominik Czaplicki; Monika Kujdowicz; Krystyna Stalinska; Joanna Bereta; Krzysztof Szczubialka; Dariusz Pawlak; Maria Nowakowska; Andrzej Mogielnicki
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.